Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
61
VCEL Quote, Financials, Valuation and Earnings
Last price:
$37.56
Seasonality move
:
32.96%
Day range:
$37.17 - $38.15
52-week range:
$29.24 - $63.00
Dividend yield:
0%
P/E ratio:
155.98x
P/S ratio:
7.42x
P/B ratio:
5.90x
Volume:
161.3K
Avg. volume:
601.5K
1-year change:
-34.7%
Market cap:
$1.9B
Revenue:
$237.2M
EPS (TTM):
$0.24
Analysts' Opinion
-
Consensus RatingVericel Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $55.00, Vericel Corp. has an estimated upside of 46.43% from its current price of $37.66.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $45.00 representing 100% downside risk from its current price of $37.66.
Fair Value
-
According to the consensus of 8 analysts, Vericel Corp. has 46.43% upside to fair value with a price target of $55.00 per share.
VCEL vs. S&P 500
-
Over the past 5 trading days, Vericel Corp. has overperformed the S&P 500 by 1.74% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Vericel Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Vericel Corp. has grown year-over-year revenues for 13 quarters straight. In the most recent quarter Vericel Corp. reported revenues of $67.5M.
Earnings Growth
-
Vericel Corp. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Vericel Corp. reported earnings per share of $0.10.
Enterprise value:
1.9B
EV / Invested capital:
4.42x
Price / LTM sales:
7.42x
EV / EBIT:
262.24x
EV / Revenue:
7.20x
PEG ratio (5yr expected):
0.55x
EV / Free cash flow:
91.48x
Price / Operating cash flow:
94.19x
Enterprise value / EBITDA:
109.38x
Gross Profit (TTM):
$191M
Return On Assets:
3.06%
Net Income Margin (TTM):
5.06%
Return On Equity:
4.44%
Return On Invested Capital:
3.32%
Operating Margin:
5.11%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $185.2M | $226.8M | $258.7M | $57.9M | $67.5M | |
| Gross Profit | $125.3M | $162.1M | $191M | $41.7M | $49.6M | |
| Operating Income | -$13.1M | -$1.2M | $7.1M | -$2.5M | $3.5M | |
| EBITDA | -$5M | $3.9M | $17M | -$1.1M | $6.4M | |
| Diluted EPS | -$0.22 | $0.06 | $0.24 | -$0.02 | $0.10 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $144.9M | $166.4M | $186.2M | $190.5M | $222M | |
| Total Assets | $224.1M | $248M | $318.1M | $390.4M | $453.3M | |
| Current Liabilities | $18.8M | $27M | $35.9M | $41.3M | $45.6M | |
| Total Liabilities | $67.4M | $70.2M | $113.7M | $132.9M | $131.4M | |
| Total Equity | $156.8M | $177.8M | $204.4M | $257.5M | $321.9M | |
| Total Debt | $48.6M | $43.2M | $77.8M | $91.6M | $86M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $32.2M | $46M | $59.1M | $10.2M | $22.1M | |
| Cash From Investing | -$16.8M | -$72.5M | -$42.2M | -$21.2M | -$3.4M | |
| Cash From Financing | $2.9M | $13.3M | $13.1M | $5.5M | $1.2M | |
| Free Cash Flow | $11.4M | -$12M | $20.4M | -$9.2M | $19.5M | |
VCEL
Sector
Market Cap
$1.9B
$27.8M
Price % of 52-Week High
59.62%
51.03%
Dividend Yield
0%
0%
Shareholder Yield
-1.3%
-1.55%
1-Year Price Total Return
-34.46%
-17.47%
Beta (5-Year)
1.200
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$36.76
200-day SMA
Sell
Level
$38.61
Bollinger Bands (100)
Buy
Level
32.91 - 38.41
Chaikin Money Flow
Buy
Level
425.8K
20-day SMA
Buy
Level
$37.25
Relative Strength Index (RSI14)
Buy
Level
51.87
ADX Line
Buy
Level
30.19
Williams %R
Neutral
Level
-29.156
50-day SMA
Buy
Level
$37.57
MACD (12, 26)
Buy
Level
10.17
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
464.5K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (11.3786)
Buy
CA Score
(Annual)
Level (0.5516)
Buy
Beneish M-Score
(Annual)
Level (-3.0055)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.5208)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.
Stock Forecast FAQ
In the current month, VCEL has received 7 Buy ratings 1 Hold ratings, and 0 Sell ratings. The VCEL average analyst price target in the past 3 months is $55.00.
-
Where Will Vericel Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Vericel Corp. share price will rise to $55.00 per share over the next 12 months.
-
What Do Analysts Say About Vericel Corp.?
Analysts are divided on their view about Vericel Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Vericel Corp. is a Sell and believe this share price will drop from its current level to $45.00.
-
What Is Vericel Corp.'s Price Target?
The price target for Vericel Corp. over the next 1-year time period is forecast to be $55.00 according to 8 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is VCEL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Vericel Corp. is a Buy. 7 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of VCEL?
You can purchase shares of Vericel Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Vericel Corp. shares.
-
What Is The Vericel Corp. Share Price Today?
Vericel Corp. was last trading at $37.56 per share. This represents the most recent stock quote for Vericel Corp.. Yesterday, Vericel Corp. closed at $37.66 per share.
-
How To Buy Vericel Corp. Stock Online?
In order to purchase Vericel Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get VCEL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VCEL
Sector
P/E ratio
155.98x
23.89x
PEG ratio
0.55x
-0.01x
P/B ratio
5.90x
1.82x
Price / LTM sales
7.42x
1.60x
Growth Metrics
VCEL
Sector
Revenue growth
16.58%
4.62%
Earnings growth
631.52%
10.88%
Revenue (5-year growth)
15.02%
6.5%
Earnings forecast
-$0.01
-$0.21
Profitability
VCEL
Sector
Profitability FY 2024
$172.1M
$3.5M
Return on invested capital
3.32%
-31.77%
Return on assets
3.06%
-27.96%
Return on equity
4.44%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
VCEL
Sector
Total cash
$135.4M
$26.3M
Short term investments
$41.7M
$25.7M
Total assets
$432.7M
$78M
Long term debt
$86M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Buy
78
TVTX alert for Dec 27
Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
